About
Biologics delivered to cytosol
Areas of Focus
Categories
Biologics & BiopharmaceuticalBoston & New England
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
108
By Phase
PHASE1/PHASE2: 2
By Status
NOT_YET_RECRUITING: 1RECRUITING: 1SUSPENDED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT07038824Lead Sponsor
A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping to Evaluate the Safety and Efficacy of ENTR-601-45
PHASE1/PHASE2Not yet recruiting
24 participants
Started: Sep 30, 2025 · Completed: Mar 1, 2029
NCT07037862Lead Sponsor
A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping to Evaluate the Safety and Efficacy of ENTR-601-44
PHASE1/PHASE2Recruiting
24 participants
Started: Jun 30, 2025 · Completed: Mar 28, 2029
NCT04245917Lead Sponsor
Natural History Study of MNGIE
N/ASuspended
60 participants
Started: Aug 6, 2020 · Completed: Feb 28, 2026
Locations (1)
Headquarters
Boston, MA, United States
Map
Loading map...